These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28577199)

  • 21. Valproic acid therapy inducing absence status evolving into generalized seizures.
    Shahar E; Andraus J; Sagie-Lerman T; Savitzki D
    Pediatr Neurol; 2002 May; 26(5):402-4. PubMed ID: 12057805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 23. Sodium valproate induced increased frequency of micturition and enuresis.
    Gosavi DD; Suman A; Jain M
    Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Old versus new antiepileptic drugs: the SANAD study.
    Hadzić N; Vara R; Raiman J; Mieli-Vergani G
    Lancet; 2007 Jul; 370(9584):315; author reply 315-6. PubMed ID: 17662873
    [No Abstract]   [Full Text] [Related]  

  • 25. Unusual cutaneous reaction with sodium valproate.
    Roy S; Goel D
    Neurol India; 2009; 57(2):216-7. PubMed ID: 19439862
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy.
    Fukuda Y; Watanabe H; Ohtomo Y; Yabuta K
    Nephron; 1996; 72(2):328-9. PubMed ID: 8684554
    [No Abstract]   [Full Text] [Related]  

  • 27. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
    Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroblastoma, maternal valproic acid use, in-vitro fertilization and family history of mosaic chromosome 22: coincidence or causal relationship?
    Merks JH; Ceelie N; Caron HN; Hennekam RC
    Clin Dysmorphol; 2004 Jul; 13(3):197-198. PubMed ID: 15194961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmasking of absence seizures by carbamazepine.
    Aithala G; Sztriha L
    Clin Pediatr (Phila); 2002 Mar; 41(2):119-20. PubMed ID: 11931329
    [No Abstract]   [Full Text] [Related]  

  • 30. Valproate-induced hyperammonemia as a cause of altered mental status.
    Feil D; Chuang K; Sultzer DL
    Am J Geriatr Psychiatry; 2002; 10(4):476-8. PubMed ID: 12095907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
    Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
    J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary nocturnal enuresis associated with valproic acid.
    Zaïem A; Aouinti I; Lakhoua G; Kastalli S; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2013; 68(1):59-60. PubMed ID: 23484665
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion.
    Cook AM; Zafar MS; Mathias S; Stewart AM; Albuja AC; Bensalem-Owen M; Kapoor S; Baumann RJ
    CNS Drugs; 2016 Jan; 30(1):71-7. PubMed ID: 26715390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toxic epidermal necrolysis associated to the use of valproic acid].
    Guevara-Campos J; González-De Guevara L; Berardi-Lorenzón ML; Ibrahim G; Mejías P; Agelvis MC
    Rev Neurol; 2010 Apr; 50(7):444-5. PubMed ID: 20387216
    [No Abstract]   [Full Text] [Related]  

  • 35. Lacosamide-induced valproic acid toxicity.
    Jones GL; Popli GS; Silvia MT
    Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carglumic acid for treatment of valproic acid-induced hyperammonaemia in a paediatric patient].
    Gramage Caro T; Vélez-Díaz-Pallarés M; Serna Pérez J; Bermejo Vicedo T
    Farm Hosp; 2012; 36(5):437-8. PubMed ID: 22858088
    [No Abstract]   [Full Text] [Related]  

  • 37. Asymptomatic hyperammonemia in children treated with valproic acid.
    Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L
    J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804
    [No Abstract]   [Full Text] [Related]  

  • 38. Protocols for identifying drug-nutrient interactions in patients: the role of the dietitian.
    Sanford MG; Ryan C; Cummings AD; Hunt A; Hackes B
    J Am Diet Assoc; 2002 May; 102(5):729-30; discussion 730-1. PubMed ID: 12009003
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid.
    Schneider S
    West J Med; 1980 Jan; 132(1):64-5. PubMed ID: 6769253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.